Symrise stock
SY1.DEXETRASymrise AG, Basic MaterialsISIN DE000SYM9999WKN SYM999
60Score 60 out of 100, Neutral
Price and trend
76 / 100
Price history
+32% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 16% above it.
Since May 2026 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 42).
The price is 5.2% below its 52-week high. Largest decline in 20 years: 68% (July 2007 to March 2009).
Chart figures for advanced users
- SMA 50$104.34
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$93.20
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)42
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$74.51
- The lowest closing price of the last twelve months.
- Resistance$113.83
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Symrise AG belongs to the Chemicals (Specialty) industry (Germany) and, with a market value of $14.8B, is number 21 of 108 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $5.48B (down 1.4% year on year) and earnings of $277.4M (down 47.9%).
- For fiscal 2026, analysts expect on average revenue of $5.61B (up 2.2%) and adjusted earnings per share of $4.33.
Show more
- MEQIRI Score 60 out of 100 (Neutral): rank 214 of 467 in Basic Materials, median 58.
- The P/E is 54.5 (Chemicals (Specialty) median 24.4, own median of recent years 39.8).
- Our model puts fair value at $77.69, with the price 37% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Earnings turn into cashFree cash flow 209% of earnings over the last 12 months.Fundamentals 85
- Reliable dividendNo dividend cut for 18 years.
- Consistently profitableProfit in all 10 fiscal years from 2016 to 2025.Fundamentals 85
Weaknesses
- Richly valuedP/E 54.5, Chemicals (Specialty) median 24.4, own median 39.8.Valuation 33
Its standout strengths are fundamentals and stability, while growth and valuation hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Fundamentals are strong, with stable profits and strong cash generation.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk low
How well MEQIRI warnsOne of the 30% with the lowest crash risk among stocks ranked 101 to 1,000.
From 2016 to 2025, 9 in 100 such stocks fell 30% or more within a year, against a group average of 15 in 100.
What drives the risk
- cyclical sector (energy or materials), as a group, crashed more often in the backtest
What lowers it
- calm price action
- solid fundamentals
- price near its 52-week high
Valuation
Valuation signal
Modestly overvaluedClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $55.49 and expensive above $129.48 (uncertainty high, one part of the fair value is more than twice the other).
The two parts of the fair value come to $107.14 (cash-flow model) and $48.23 (industry comparison), and the gap between them shows how uncertain the estimate is.
Calculated with a cost of equity of 7.1%. At 8.1% the fair value would be $68.55, at 6.1% it would be $91.41.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (24.4).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In fiscal 2025, revenue fell 1.4% on the prior year. Revenue has grown solidly since 2006, at about 8% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 38%, operating 12%, net 5%.
Debt & balance sheet
latest quarterModerate debt, and interest is adequately covered.
Earnings
- Next earnings
- 10 Mar 2027in 118 days
- Last reported
- 30 Jul 2026EPS reported $2.10 (expected $2.08)in line with expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $4.33−0.4%
- Revenue
- $5.61B+0.3%
- Earnings per share
- $4.82−0.6%
- Revenue
- $5.87B+0.4%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook confirmed
Share price after the results: 0.0%2026 outlook reaffirmed: organic growth of 2% to 4% and adjusted EBITDA margin of 21.5% to 22.5%.
“We continue to expect organic growth of 2% to 4%, adjusted EBITDA margin of 21.5% to 22.5% and an adjusted business free cash flow margin above 14%. Q2 organic sales growth rate of 4.5% is a run rate needed to support full year guidance after a softer Q1.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 30 Jul 2026 (fiscal Q2 2026), read by AI.
What happened at Symrise
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
467 rated companies in Basic Materials
- This company
- 60
- Sector median
- 58
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- Solar Industries IndiaSOLARINDS.NS $18.32B74
- Pidilite IndustriesPIDILITIND.NS $17.12B79
- Nippon Sanso Holdings4091.T $16.34B71
- Sociedad Química y Minera de ChileSQM $15.64B71
- Swancor Advanced Materials688585.SS $14.53B48
- Nitto Denko6988.T $14.02B74
- Covestro1COV.DE $13.95B43
- Formosa Plastics1301.TW $13.6B42
ETFs that hold Symrise
Held by 133 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares STOXX Europe 600 Chemicals UCITS ETF (DE)EXV7 | 5.50% | 0.46% | €114.14M |
| Rize Sustainable Future of Food UCITS ETFRIZF | 2.02% | 0.45% | €59.51M |
| State Street SPDR MSCI Europe Materials UCITS ETFSPYP | 1.92% | 0.18% | €109.81M |
Show 5 more
| Xtrackers MSCI Europe Materials Screened UCITS ETF 1CDXSC | 1.84% | 0.17% | €66.76M |
| iShares EURO STOXX Mid UCITS ETFIQQM | 1.57% | 0.40% | €558.1M |
| UBS Factor MSCI EMU Low Volatility UCITS ETF EUR disUIMY | 1.25% | 0.25% | €9.25M |
| Deka DAX ex Financials 30 UCITS ETFELF0 | 1.23% | 0.31% | €19.34M |
| Amundi DAX 50 ESG II UCITS ETF DistE909 | 1.14% | 0.15% | €323.69M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 11 Nov 2026 ($1 = €0.8987)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 31 Jul 2023)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.